Background Procalcitonin is a promising marker for identification of bacterial infections. We
assessed the accuracy and clinical value of procalcitonin for diagnosis of sepsis in critically …

Sepsis is a leading cause of mortality in critically ill patients. Delay in diagnosis and initiation
of antibiotics have been shown to increase mortality in this cohort. However, differentiating …

Objective: There is increasing interest for strategies that could curtail antibiotic resistance in
the critical care setting. We sought to determine the effectiveness and safety of procalcitonin …

Background Sepsis is one of the most common diseases that seriously threaten human
health. Although a large number of markers related to sepsis have been reported in the last …

BACKGROUND: Circulating biomarkers can facilitate sepsis diagnosis, enabling early
management and improved outcomes. Procalcitonin (PCT) has been suggested to have …

Sepsis has become a major health economic issue, with more patients dying in hospitals
due to sepsis related complications compared to breast and colorectal cancer together …

Background: Sepsis is defined as systemic inflammatory response syndrome (SIRS) in the
context of an underlying infectious process, and is associated with high rates of morbidity …

OBJECTIVES: Serum procalcitonin is often ordered at admission for patients with suspected
sepsis and bloodstream infections (BSIs), although its performance characteristics in this …

Respiratory infections remain the most common reason why patients seek medical care in
ambulatory and hospital settings, and they are the most frequent precursor of sepsis. In light …

Introduction: Sepsis is defined as life-threatening organ dysfunction in result of the host's
dysregulated response to infection and septic shock. Sepsis-associated kidney injury is …